E. D. Bateman (Cape Town, South Africa), M. Spears (Glasgow, United Kingdom)
Asthma in real life: management in adult patients in a busy district general hospital
M. Gleave, N. Karia, T. Bycroft, A. Manuel, R. Russell (Slough, United Kingdom)
|  |
Asthma control questionnaire score (ACQ-5) predicts future risk of exacerbations
E. D. Bateman, H. K. Reddel, S. Peterson, G. Eriksson, P. M. O‘Byrne (Cape Town, South Africa; Sydney, Australia; Lund, Sweden)
| |
Acinar effect of inhaled steroids therapy evidenced by exhaled nitric oxide
A. Van Muylem, Y. Kerckx, A. Michils (Brussels, Belgium)
|  |
The effect of inhaled corticosteroids on the hypothalamic-pituitary-adrenal-axis in short term and long term treatment
G. Makrantoni, M. Tzanela, E. Balis, A. Kotanidou, S. Orfanos, C. Roussos (Athens, Greece)
| |
Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Q. Ma, Q. Zhang, C. Wang (Chongqing, China)
| |
Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
C. Suppli Ulrik, Z. Diamant (Hvidovre, Denmark; Leiden, Netherlands)
| |
The additional effects of pranlukast on SFC treatment in asthmatic distal airway
H. Ohbayashi, N. Shibata, M. Adachi (Mizunami, Tokyo, Japan)
| |
Long-term safety of inhaled formoterol in adult asthma patients
P. Happonen, M. Härkönen, R. Vaheri, P. Rytilä (Kuopio, Espoo, Finland)
| |
Effect of omega-3 fatty acid (O3FA) from fish oils on mannitol-induced airway hyperresponsiveness (AHR) & sputum eosinophils in patients with asthma
J. Brannan, A. Alkabaz, J. Otis, A. Efthimiadis, K. Radford, P. Nair, P. O‘Byrne (Hamilton, Canada)
| |
Assessment and treatment of vocal cord dysfunction in the chest clinic
V. K. Reay, I. Susnerwala, J. Haines, R. B. Gore, A. Vyas, S. J. Fowler (Preston, United Kingdom)
| |
The effect of esomeprazole 40mg once or twice daily on asthma outcome
T. Kiljander, O. Junghard, O. Beckman, T. Lind (Turku, Finland; Mölndal, Sweden)
| |
Scientific rationale for using a single inhaler for asthma control by comparison of the effectiveness and safety of formoterol/budesonide turbuhaler as physician-guided adjustable maintenance dosing regimen versus formoterol/budesonide given as fixed dose of twice daily therapy in the management of bronchial asthma
O. Obodo, O. Ige, C. Chukwu (Ikeja, Ibadan, Lagos, Nigeria)
| |
Efficacy of fluticasone propionate/salmeterol combination compared to fluticasone propionate alone in patients allergic to house dust mite (our experience)
G. Breskovska, B. Kaeva, J. Stojkovic, G. Stevcevska (Skopje, Fyrom)
| |
Control of asthma at the 3rd-line pulmonary diseases clinics (3rd line pdc) according GINA (global initiative for asthma) parameters
B. Gemicioglu, F. Yildiz, M. Polatli, S. Atis, A. B. Dursun, F. Oner Erkekol, H. Turker, B. Ocakli, G. Camsari, A. Gur, S. Kepil Ozdemir, O. Aydin, O. Abadoglu, A. Cimrin, M. L. Erkan, H. Günen, O. Goksel (Istanbul, Kocaeli, Aydin, Mersin, Ankara, Sivas, Izmir, Samsun, Malatya, Turkey)
| |
Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics
K. Matsunaga, T. Kawayama, R. Toda, Y. Imamura, T. Hoshino, H. Aizawa (Kurume, Japan)
| |
Use of heated heliox-driven nebulizer therapy in the treatment of patients with bronchial asthma
S. Grigoriev, H. Loshkareva, O. Aleksandrov, I. Zolkina, U. Grechanaya (Moscow, Russian Federation)
| |
Relationship between inhaled corticosteroids and female sex hormones: their impact on bone metabolism in fertile asthmatic women
N. Azab, M. Aboul Sood, G. Sharara, E. Abdel-Atti, H. Maklad (Shebin Elkom, alexandria, Egypt)
| |
Impediments to the start of omalizumab in a small pulmonary practice
A. Redford, M. L. Zaremba, S. Ali, N. Shah, S. Reddy (Port Huron, United States Of America)
| |
Comparison of extended flow nitric oxide parameters in smokers and non-smokers with asthma before and after an oral corticosteroid trial
M. Spears, C. Weir, J. Thompson, M. Brannigan, J. Lafferty, R. Chadhuri, G. Braganza, E. Cameron, N. Thomson (Glasgow, United Kingdom)
| |
Stability of overall asthma control achieved with budesonide/formoterol maintenance + reliever therapy
E. D. Bateman, H. K. Reddel, S. Peterson, O. Ostlund, G. Eriksson, P. M. O‘Byrne (Cape Town, South Africa; Sydney, Australia; Lund, Sweden)
| |